Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term Clinical trial
- 29 February 1996
- Vol. 18 (2), 179-184
- https://doi.org/10.1016/8756-3282(95)00442-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Use of Clodronate in Disorders of Calcium and Skeletal Metabolism1Published by S. Karger AG ,2015
- Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapyJournal of Bone and Mineral Research, 1995
- Rationale for the use of alendronate in osteoporosisOsteoporosis International, 1995
- A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosisOsteoporosis International, 1994
- Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral densityJournal of Bone and Mineral Research, 1993
- Effects of one-year cyclical treatment with clodronate on postmenopausal bone lossBone, 1993
- Estrogen: Effects and actions in osteoporosisOsteoporosis International, 1993
- Bisphosphonates in osteoporosis?Osteoporosis International, 1993
- Prevention and treatment of osteoporosis: A review of current modalitiesBone, 1992
- TREATMENT OF OSTEOPOROTIC FRACTUREThe Lancet, 1984